GeneDx is trading 4.06% up at $87.37, moving alongside a broadly stronger market on September 11, 2026.

  • The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are each up more than 1%, supporting positive risk sentiment.
  • No new GeneDx announcement appears on September 11; its latest release was the September 9 NPC GenomeComplete collaboration with Beren Therapeutics.